• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The use of rituximab in two children with allo-antibodies towards factor VIII.

作者信息

Curry Nikki, Stanworth Simon, Keeling David

出版信息

Br J Haematol. 2006 Apr;133(2):214-6. doi: 10.1111/j.1365-2141.2006.06048.x.

DOI:10.1111/j.1365-2141.2006.06048.x
PMID:16611318
Abstract
摘要

相似文献

1
The use of rituximab in two children with allo-antibodies towards factor VIII.利妥昔单抗在两名对凝血因子 VIII 产生同种抗体的儿童中的应用。
Br J Haematol. 2006 Apr;133(2):214-6. doi: 10.1111/j.1365-2141.2006.06048.x.
2
Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia.利妥昔单抗治疗两名重度血友病儿童的同种免疫性凝血因子 VIII 和 IX 抗体
Br J Haematol. 2004 May;125(3):366-8. doi: 10.1111/j.1365-2141.2004.04916.x.
3
Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.利妥昔单抗用于治疗对传统化疗难治的高滴度获得性凝血因子VIII抑制物患者。
Haemophilia. 2007 Jan;13(1):46-50. doi: 10.1111/j.1365-2516.2006.01342.x.
4
Rituximab in the treatment of acquired factor VIII inhibitors.利妥昔单抗治疗获得性凝血因子VIII抑制物。
Thromb Haemost. 2006 Jul;96(1):84-7. doi: 10.1160/TH06-03-0183.
5
[Development of inhibitor against hemophilia and prevention and management strategies forpatients with hemophilia].[血友病抑制剂的研发及血友病患者的预防与管理策略]
Zhonghua Er Ke Za Zhi. 2013 Aug;51(8):631-4.
6
Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature.获得性血友病：2例接受利妥昔单抗联合短期类固醇治疗的获得性凝血因子VIII抑制物患者的病例报告及文献复习
Clin Appl Thromb Hemost. 2007 Oct;13(4):443-8. doi: 10.1177/1076029607303777.
7
Rituximab as a single agent in the management of adult patients with haemophilia A and inhibitors: marked reduction in inhibitor level and clinical improvement in bleeding but failure to eradicate the inhibitor.利妥昔单抗单药治疗成年甲型血友病伴抑制物患者：抑制物水平显著降低，出血症状临床改善，但未能根除抑制物。
Haemophilia. 2009 Jan;15(1):210-6. doi: 10.1111/j.1365-2516.2008.01865.x.
8
Successful treatment with rituximab in an elderly patient with acquired factor VIII inhibitor.
Geriatr Gerontol Int. 2009 Jun;9(2):197-9. doi: 10.1111/j.1447-0594.2008.00491.x.
9
Rituximab in postpartum-related acquired hemophilia.利妥昔单抗用于产后相关获得性血友病
Am J Med. 2006 Jan;119(1):86-8. doi: 10.1016/j.amjmed.2005.06.068.
10
Factor VIII inhibitor eradication with bortezomib in acquired haemophilia A.硼替佐米用于获得性血友病A中消除VIII因子抑制剂
Br J Haematol. 2017 Sep;178(6):986-987. doi: 10.1111/bjh.14185. Epub 2016 Jul 19.

引用本文的文献

1
Treatment with rituximab in benign and malignant hematologic disorders in children.利妥昔单抗在儿童良性和恶性血液系统疾病中的治疗应用。
J Pediatr. 2007 Apr;150(4):338-44, 344.e1. doi: 10.1016/j.jpeds.2006.12.038.